The PROSTATE-IQ trial uses the ArteraAI Prostate Test to personalize treatment for prostate cancer recurrence post-prostatectomy, potentially reducing hormone therapy use. The trial stratifies ...

A 68-year-old man presented to the emergency department with haematuria and penile pain. His medical history included benign prostatic hyperplasia, but no follow-up examinations had been performed.

About 1 in 8 men will get prostate cancer in their lifetime. But a new study concludes an increasing number of men with limited life expectancy are being overtreated for the disease with procedures ...

Prostate cancer patients could have a new treatment on the horizon. A new study published in the journal Nature has found that for some patients with treatment-resistant prostate cancer, a new process ...

Although overall quality of life was not improved with app support, use of the app had a positive effect on bowel symptoms 3 weeks after treatment. A specialized app that helps with symptom monitoring ...

A newly expanded prostate cancer drug could bring new hope to patients with a common form of the disease. Novartis, a Switzerland-based pharmaceutical company, announced on March 28 that the U.S. Food ...

Growing evidence indicates that more patients with favorable Grade Group 2 prostate cancer can be successfully managed with active surveillance and achieve acceptable oncologic outcomes, even if later ...

Effective cancer screening protocols can dramatically alter outcomes for patients. Prostate cancer, for example, has been one of the most common cancers among men in the United States for decades. In ...

Prostate cancer is a type of cancer that develops in the prostate gland. It is a small walnut-sized organ located just below the bladder in men. The prostate gland plays a crucial role in the male ...